Categories

Meta

Recent Posts

Archive for the 'Medical Patent' Category

Medifocus receives two patents to distend IP portfolio

Posted in Medical Patent on October 18th, 2010

Medifocus, Inc. (OTC:MDFZF.PK and TSXV:MFS) is on top of the world to tell that it has recently received notification of allowances against two additional universal patents to expatiate on its worldwide Authority Properties (IP) portfolio in joining to the patents Medifocus has exclusively licensed from the Massachusetts Found of Technology (MIT). The centre MIT patents allows the Party to exhibit tumor-targeted focused tension treatment systems Read the rest of this entry »

U.S. Community Court issues finding in NPWT unequivocal action

Posted in Medical Patent on October 18th, 2010

The U.S. Partition Court with a view the Western Partition of Texas has issued a resolution in the flagrant suit between Kinetic Concepts, Inc. (NYSE:KCI), Wake Forest University and Smith & Nephew, Inc. The Court held that the clear claims licensed generally KCI from Wake Forest University and asserted in this case are incorrect. KCI desire resume to analyze the Court’s ruling and assess its next steps including, quantity other options, a insist Read the rest of this entry »

USPTO grants HemoShear permit after humanitarian cell-based surrogate systems

Posted in Medical Patent on October 14th, 2010

HemoShear LLC, a biotechnology study band and supreme developer of child cell-based surrogate systems recompense idea and assessment of redesigned antidepressant compounds, today announced that the U.S. Licence and Trademark Division (USPTO) has granted it blatant no. 7,811,782 entitled "Use of An In Vitro Hemodynamic Endothelial/Smooth Muscle Apartment Co-Culture Representation to Home in on Modish Restorative Targets in return Vascular Read the rest of this entry »

Biomerix receives USPTO franchise inasmuch as Biomaterial pile scaffold

Posted in Medical Patent on October 14th, 2010

Biomerix Corporation today announced that the Of like mind States Certificate of invention and Trademark Aid (USPTO) has granted a unmistakable in the direction of its proprietary biomaterial principles technology titled "Reticulated elastomeric matrices, their putting together and utility in implantable devices." The Company’s stage technology, the Biomerix Biomaterial™ is a non-resorbable reticulated, polycarbonate polyurethane-urea, Read the rest of this entry »

Proveris issues declaration on Innova’s marketing of evident infringing ADSA organization

Posted in Medical Patent on October 14th, 2010

Proveris Meticulous today issued the following utterance:

“We are surprised and saddened that Innova has persisted in selling their infringing system”

Believe William G. Brood, Unified States Department Court to save the Locality of Massachusetts, has ruled that InnovaSystems, Inc. ("Innova") is in loathing of court in spite of violating the court’s unchanging commandment entered in May 2007. The court rejected Read the rest of this entry »

Immunomedics receives additional control claims representing antibody cure

Posted in Medical Patent on October 14th, 2010

Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical concern largely focused on the happening of monoclonal, antibody-based products in the course of the targeted treatment of cancer, autoimmune and other unsmiling diseases, today announced that additional claims to the palpable kids "Method and tools exchange for imaging and toothache organs and conglomeration," were issued as U.S. Copyright No. 7,811,570. The brand-new prominent Read the rest of this entry »

TrovaGene receives unequivocal suited for diagnosis and monitoring of pathogenic infection

Posted in Medical Patent on October 14th, 2010

TrovaGene, Inc. (Pink Sheets:TROV), a developer of transrenal molecular diagnostics to expedite monogrammed medicament, received pay of U.S. Copyright 7,803,929 entitled "Kits after diagnosis and monitoring of pathogenic infection ;mainly enquiry of cell-free pathogenic nucleic acids in urine."

“Kits looking for diagnosis and monitoring of pathogenic infection in the main examination of cell-free pathogenic nucleic acids Read the rest of this entry »

Auxilium receives USPTO self-evident in return XIAFLEX by-product

Posted in Medical Patent on October 14th, 2010

Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL), a specialty biopharmaceutical flock, today announced that the Joint States Prominent and Trademark Auspices ("USPTO") issued U.S. Self-evident No. 7,811,560 claiming, to each other things, purified collagenase, the operative component in Auxilium’s commodity XIAFLEX® (collagenase clostridium histolyticum).  The control entitled "COMPOSITIONS AND METHODS ON JOCULAR TUMMY ROT COLLAGEN-MEDIATED Read the rest of this entry »

Dyadic Intercontinental receives sixth USPTO tangible

Posted in Medical Patent on October 13th, 2010

Dyadic Worldwide, Inc. ("Dyadic") (Pink Sheets: DYAI), a wide-ranging biotechnology presence focused on the conception, happening, make up and transaction of enzyme and protein products and solutions in place of the bioenergy, industrial enzyme and biopharmaceutical industries, announced today that it has been issued U.S. Transparent No. 7,794,962 usually the Combined States Control and Trademark Support ("USPTO").

The tale Read the rest of this entry »

Lithera receives Note of Credit from USPTO for the sake LIPO-102 tangible persistence

Posted in Medical Patent on October 13th, 2010

Lithera, Inc. today announced proceeds of a Observe of Admission from the U.S. Grant and Trademark Responsibility quest of a grant commitment broadly covering compositions and methods of put associated with LIPO-102, its narrative injectable amalgamation of salmeterol xinafoate (SX) and fluticasone propionate (FP) for the treatment of picky, non-ablative well-to-do reduction.

In days of yore issued, this grant choose sacrifice the companions Read the rest of this entry »